1,196
Views
8
CrossRef citations to date
0
Altmetric
Author's View

New insights into the mechanism of action of immune checkpoint antibodies

, &
Article: e954869 | Received 07 Jul 2014, Accepted 11 Jul 2014, Published online: 29 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anje Cauwels, Sandra Van Lint, Geneviève Garcin, Jennyfer Bultinck, Franciane Paul, Sarah Gerlo, José Van der Heyden, Yann Bordat, Dominiek Catteeuw, Lode De Cauwer, Elke Rogge, Annick Verhee, Gilles Uzé & Jan Tavernier. (2018) A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment. OncoImmunology 7:3.
Read now
Laura Rosa Brunet, Thorsten Hagemann, Andrew Gaya, Satvinder Mudan & Aurelien Marabelle. (2016) Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?. OncoImmunology 5:4.
Read now

Articles from other publishers (6)

Diane Letourneur, François-Xavier Danlos & Aurélien Marabelle. (2020) Chemokine biology on immune checkpoint–targeted therapies. European Journal of Cancer 137, pages 260-271.
Crossref
Kuan-Yin Shen, Hsin-Yu Liu, Wan-Lun Yan, Chiao-Chieh Wu, Ming-Hui Lee, Chih-Hsing Leng & Shih-Jen Liu. (2020) Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells. Cancers 12:4, pages 810.
Crossref
Anje Cauwels, Sandra Van Lint, Franciane Paul, Geneviève Garcin, Stefaan De Koker, Alexander Van Parys, Thomas Wueest, Sarah Gerlo, José Van der Heyden, Yann Bordat, Dominiek Catteeuw, Elke Rogge, Annick Verhee, Bart Vandekerckhove, Niko Kley, Gilles Uzé & Jan Tavernier. (2018) Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments. Cancer Research 78:2, pages 463-474.
Crossref
Paul E. Clavijo, Ellen C. Moore, Jianhong Chen, Ruth J. Davis, Jay Friedman, Young Kim, Carter Van Waes, Zhong Chen & Clint T. Allen. (2017) Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells. Oncotarget 8:34, pages 55804-55820.
Crossref
Claire Deligne, Benoît Milcent, Nathalie Josseaume, Jean-Luc Teillaud & Sophie Sibéril. (2017) Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?. Frontiers in Immunology 8.
Crossref
M. Angela Aznar, Nicola Tinari, Antonio J. Rullán, Alfonso R. Sánchez-Paulete, María E. Rodriguez-Ruiz & Ignacio Melero. (2017) Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally. The Journal of Immunology 198:1, pages 31-39.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.